We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

41 hedge funds and large institutions have $38.9M invested in Genocea Biosciences, Inc. in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

256% more call options, than puts

Call options by funds: $313K | Put options by funds: $88K

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

3% more funds holding

Funds holding: 40 → 41 (+1)

40% less capital invested

Capital invested by funds: $65.3M → $38.9M (-$26.4M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
0.63%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
7
Reduced
6
Closed
4
Calls
$313K
Puts
$88K
Net Calls
+$225K
Net Calls Change
-$23K

Top Buyers

Rank Fund Capital Flow
1
Simplex Trading
Simplex Trading
Illinois
+$46.2K
2
Renaissance Technologies
Renaissance Technologies
New York
+$41K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$32.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$31.2K
5
Northern Trust
Northern Trust
Illinois
+$21.4K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$270K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$179K
3
Two Sigma Investments
Two Sigma Investments
New York
-$111K
4
Citadel Advisors
Citadel Advisors
Florida
-$86.9K
5
Group One Trading
Group One Trading
Illinois
-$26.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$19K – – –
PCA
27
Personal Capital Advisors
California
$17K – – –
WA
28
WealthTrust Axiom
Pennsylvania
$17K – – –
Morgan Stanley
29
Morgan Stanley
New York
$15K -$3.03K -2,033 -13%
VF
30
Virtu Financial
New York
$15K +$18.6K +12,503 New
CAAS
31
Capital Asset Advisory Services
Michigan
$14K – – –
EAM
32
Empirical Asset Management
Massachusetts
$12K +$14.9K +10,000 New
Wells Fargo
33
Wells Fargo
California
$11K -$307 -206 -2%
VRM
34
Vectors Research Management
New York
$7K – – –
TRCT
35
Tower Research Capital (TRC)
New York
$7K +$232 +156 +3%
ACM
36
ACT Capital Management
Pennsylvania
$6K – – –
First Manhattan
37
First Manhattan
New York
$2K – – –
AWA
38
Artemis Wealth Advisors
New York
$1.32K – – –
CG
39
Cutler Group
California
$1K – – –
Federated Hermes
40
Federated Hermes
Pennsylvania
$1K – – –
UBS Group
41
UBS Group
Switzerland
$1K +$1.68K +1,129 New
Two Sigma Investments
42
Two Sigma Investments
New York
– -$111K -57,836 Closed
JMPWA
43
JP Morgan Private Wealth Advisors
California
– -$24K -12,285 Closed
Osaic Holdings
44
Osaic Holdings
Arizona
– -$2K -800 Closed
Northwestern Mutual Wealth Management
45
Northwestern Mutual Wealth Management
Wisconsin
– -$1K -625 Closed
1
2

GNCA Hedge Fund Activity: Q4 2021 in Review

41 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q4 2021, worth a combined $38.9M — down 40% from $65.3M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new GNCA positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 6 trimmed.

The largest buyer was Simplex Trading, opening a new position worth an estimated $46.2K. The largest seller was Millennium Management, cutting an estimated $270K.

  • 41 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q4 2021, up from 40 in Q3 2021.
  • Funds reported $38.9M of Genocea Biosciences, Inc. stock for Q4 2021, down 40% quarter-over-quarter.
  • 6 funds opened new Genocea Biosciences, Inc. positions in Q4 2021 and 4 closed out, a net change of +2 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q4 2021 was Simplex Trading, an estimated $46.2K added.
  • The largest Genocea Biosciences, Inc. seller in Q4 2021 was Millennium Management, an estimated $270K sold.

Based on aggregated 13F filings for Q4 2021.